Container for news
Pepscan and Zealand Pharma awarded grant for novel peptide drugs
Pepscan Holding and Zealand Pharma announced the joint award of an EU research and development grant of EUR 860,000.
Abbott licenses anti-inflammatory compound from Biotest
Biotest granted Abbott Laboratories rights to BT-061, a drug candidate in midstage development for psoriasis and rheumatoid arthritis.
BAC collaborates with Life Technologies
BAC BV, provider of antibody-based affinity purification technology, has announced a strategic collaboration with Life Technologies, the global manufacturer of molecular diagnostic and research-use products, to bring the wide range of BAC’s CaptureSelect affinity ligand specificities to Life Technologies’ POROS chromatography media and pre-packed HPLC columns.
UvA best comprehensive university in valorization ranking
Of all Dutch comprehensive universities, the University of Amsterdam (UvA) is best at using its scientific potential for economic and social profit.
Sanofi collaborates with Audion
Sanofi has entered into a two-year research collaboration with the Amsterdam-based biopharmaceutical company Audion Therapeutics to develop potential treatments for hearing loss through the optimization of small molecules by using a regenerative medicine approach.
Sekisui and Avantium work together
Sekisui Chemical Company and Avantium have entered into a collaboration agreement.
to-BBB starts clinical trial brain metastases
to-BBB, the Dutch brain drug delivery company, has received approval to start treating patients with brain metastases with its lead product 2B3-101 in a Phase I/II clinical trial.
ORCA patents oncolytic adenovirus technology
ORCA Therapeutics, a pioneer in the development of innovative virotherapies for treatment of cancer, has secured key intellectual property rights for its T1 oncolytic adenovirus technology.
Camozzi chief medical officer AMT
Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, has appointed Dr. Carlos R. Camozzi as Chief Medical Officer.
DCPrime receives €1.4 million government loan
The Dutch Ministry of Economic Affairs, Agriculture and Innovation (AgentschapNL) has decided to support DCPrime for its acute myeloid leukemia (AML) program by granting the company an “Innovation Credit” (soft loan) of €1.4 million.
Emultech and to-BBB collaborate
Drug delivery development company EmulTech and brain drug delivery company to-BBB have announced a collaborative partnership.
KP7 Calls now open
The European Commission has opened several new KP7 calls on July 20th, among which a Health call.
Agendia Receives €1.27 Million in EU Funding
Agendia, a global innovator in molecular cancer diagnostics, together with thought-leading collaborators in clinical centers and translational research groups, has launched the RATHER (Rational Therapy for Breast Cancer) and COLTHERES (Colon Cancer and Therapeutics) consortiums.
Fornix slightly positive about 2011
Fornix BioSciences posted a satisfactory result for the first half of 2011, considering the circumstances.
Genzyme and Isis apply for marketing authorization Mipomersen
Submission seeks approval for Mipomersen’s use in the treatment of homozygous familial hypercholesterolemia and severe heterozygous familial hypercholesterolemia.
EU clears Takeda's takeover of Nycomed
The European Commission cleared the acquisition of Swiss pharmaceutical company Nycomed by Takeda Pharmaceutical of Japan.
Partnership Norgine and Alimentary Health
Alimentary Health has entered a partnership with Norgine on the development of medicinal products using AH technology.
Norgine and Nycomed Sign Licence Agreement for Moviprep
Norgine and Nycomed have entered into a licensing agreement that gives Nycomed the exclusive rights to commercialise Moviprep, the world’s leading bowel cleansing brand, in Russia, Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Mongolia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.
Lonnqvist Chief Medical Officer to-BBB
to-BBB, the Dutch brain drug delivery company, has announced Fredrik Lonnqvist as the company’s Chief Medical Officer.
Bayer Healthcare acquires Pathway Medical Technologies
Forbion Capital Partners announces that Medrad, a subsidiary of Bayer Healthcare, has acquired portfolio company Pathway Medical Technologies for an undisclosed sum.
AMT gains US Patent Protection
Amsterdam Molecular Therapeutics (AMT) has entered into an exclusive license agreement with the US National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications.
Netherlands signs on to infrastructure for biological information
Five countries plus the European Molecular Biology Laboratory (EMBL) have signed a Memorandum of Understanding to catalyse the implementation and construction of ELIXIR, Europe’s emerging research infrastructure for life-science information.
SBI successful new Bachelor of Sciences at VU
Started in 2007, the Bachelor Science, Business & Innovation (SBI)at VU University in Amsterdam, the Netherlands, has grown steadily over the years to become the largest Bachelor education program in the Sciences Faculty, with over 200 students enrolled.
Amsterdam inbusiness appoints dedicated LS acquisitor
Kelly Trommels has been appointed on 1 September as dedicated life sciences acquisitor for the Amsterdam Metropolitan Area. The appointment, initiated by the Amsterdam BioMed Cluster, is in line with the ambitions of the Economic Development Board to achieve a leading life sciences cluster by 2020.
Erasmus MC uses Tispa Tissue Processor
Erasmus MC has taken a big step towards reducing the use of pollutants by installing the first Tispa Tissue Processor in its pathology lab.
Biogen Idec: strong second quarter
Biogen Idec, a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2011 results.
Niaba BioBusiness Masterclass 2011 open for registration
Niaba BioBusiness Masterclass, which will start in October 2011, is now open for registration.
AM-Pharma Raises €29.2m in Series D Financing
AM-Pharma, a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, has raised €29.2m in Series D financing.
Kingsley to Run Global Commercial Operations Biogen Idec
29 September 2011 - Biogen Idec announced that Tony Kingsley has been promoted to Executive Vice President, Global Commercial Operations, effective Nov. 7.
QuantiVision facilitates optimal analysis of medical images
1 September 2011 - Institute QuantiVision will develop medical imaging devices, software and protocols for quantitative analysis of medical images to guide therapy and facilitate therapeutic interventions, with a focus on oncology and neurology. The institute was opened on September 21, 2011.
AVL and UMC Utrecht work together
3 October 2011 - The Antoni van Leeuwenhoek hospital (AVL) and UMC Utrecht are establishing a new organisation for diagnostics, treatment and research in the field of oncology.
to-BBB awarded grant for development of stroke therapy
29 September 2011 - NeuroVive Pharmaceutical and to-BBB, the Dutch brain drug delivery company, have been awarded a grant of €1 million through the Eureka Eurostars program for the joint development of therapies for stroke and other acute neurological conditions.
Grants for young Amsterdam researchers
18 October 2011 - The Netherlands Organisation for Scientific Research (NWO) has awarded no less than 39 out of 159 Veni grants to young researcher from Amsterdam (25%). Of these, half are in the field of life sciences.
VUmc opens new cancer center
September 28, 2011 - VUmc has opened the VUmc Cancer Center Amsterdam: a modern center for diagnosis and treatment of patients with cancer.
BioBusiness Summer School 2012 registration open
October 31, 2011 - In 2012, BioBusiness Summer School will take place from June 25th – 29th in Amsterdam.
Boehringer licenses HIV drugs to Gilead
6 October 2011 - Boehringer Ingelheim and Gilead Sciences have entered into a licensing agreement, under which Boehringer Ingelheim has granted Gilead exclusive worldwide rights for the research, development and commercialization of its novel non-catalytic site integrase inhibitors (NCINIs) for HIV.
Merck Total Revenues Increase by 4%
26 October 2011 - The Merck Group produced solid third-quarter revenue growth in a difficult environment, driven mainly by good performances from the Merck Serono and Merck Millipore divisions.
Merck and Ono Form Collaborations for MS and Cancer
October 4, 2011 – Merck signed two agreements for collaboration of its Merck Serono division with Ono Pharmaceutical, Osaka, Japan to strengthen its multiple sclerosis and cancer franchises.
Merck Returns Rights for Safinamide to Newron
October 21, 2011 – Merck KGaA has decided to return all rights for safinamide to Newron Pharmaceuticals S.p.A.
Abbott to Separate into Two Companies
October 19, 2011 - Abbott announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.
AMT will reduce staff by half
October 25, 2011 – Amsterdam Molecular Therapeutics (AMT) today provided an update on operations and disclosed the outcome of a strategic review of its gene therapy product pipeline.
David Meeker New CEO of Genzyme
October 24, 2011 - Sanofi announced today the appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1, 2011.
Global Collaboration Biogen Idec and Portola
October 27, 2011 - Biogen Idec and Portola Pharmaceuticals have entered into an exclusive, worldwide collaboration and license agreement under which both companies will develop and commercialize highly selective, novel oral Syk inhibitors for the treatment of various autoimmune and inflammatory diseases, including rheumatoid arthritis and systemic lupus erythematosus.
Biogen Idec Reports Third Quarter 2011 Results
October 28, 2011 - Third quarter revenues increased 11% to $1.3 billion, compared to the third quarter of 2010.
Norgine and Jubilant Collaborate in Gastrointestinal Therapeutic Area
October 18, 2011 - Specialty pharmaceutical company Norgine and Jubilant Biosys, subsidiary of Jubilant Life Sciences, have entered into a discovery partnership.
Forbion leads €9.6 Million Expansion Financing of Curetis
October 26, 2011 – Forbion Capital Partners, the Dutch life sciences venture capital firm, has led the expansion financing of the Series A round of Curetis AG together with Roche Venture Fund, CD-Venture and management.
Forbion participates in €7 million Financing of Hookipa
October 18, 2011 - Hookipa Biotech, a startup biotech company specialized in developing new generation vaccines, has raised €7 million Series A financing in which Sofinnova and Forbion Capital Partners participated.
AMC no longer on black list breast cancer treatment
October 31, 2011 - Health insurance company CZ has decided that the AMC will get a positive review again for its breast cancer operations.
Colorectal cancer stem cells predict effect treatment
November 4, 2011 - AMC researchers have found out that gene signatures derived from cancer stem cells predict tumor recurrence for many forms of cancer.
VUmc finds out how tumor cell tricks drugs
October 13, 2011 - Resistance to anti-angiogenic tyrosine kinase inhibitors such as sunitinib is an important clinical problem, but its underlying mechanisms are largely unknown.
ORCA receives up to €5 Million Innovation Credit
November 8, 2011 - ORCA Therapeutics, a pioneer in the development of innovative virotherapies for treatment of cancer, has received an innovation credit of up to € 5 million from Agentschap NL, an agency executing programmes for the Dutch Ministry of Economic Affairs, Agriculture and Innovation, to support development of its lead compound ORCA-010 for prostate cancer.
EuroTransBio for VUmc and SomantiX
November 7, 2011 – VU University Medical Center Amsterdam and SomantiX receive an EuroTransBio (ETB) Grant for their Tumor Vessel Targeting program.
Expensive TB test is cost-effective
November 8, 2011 - AMC research, published in PloS Medicine, indicates that Xpert MTB/RIF is a cost-effective method of TB diagnosis.
Medical business park near AMC
November 8, 2011 - The municipality of Amsterdam wants to develop a business park for medical companies near the AMC. Construction should start next year.
Execution topsector plan LSH begins
November 10, 2011 - The Life Sciences & Health sector has announced the next steps to be taken concerning the topsector plan Life Sciences & Health.
Gene locus associated with Kawasaki disease
November 13, 2011 - An AMC research team has gained insight in the development of Kawasaki disease, a rare heart condition in children.
AMC and VUmc jointly recruit temps
October 12, 2011 - From now on, AMC, Vumc and GGZ inGeest will hire temporary personnel through the new website www.marktplaatsvoordezorg.nl.
IVF and naturally conceived twins are similar
November 15, 2011 - VU researchers compared twins born after IVF to naturally conceived twins with respect to birth characteristics, growth, attainment of motor milestones, and emotional and behavioral problems.
AIMM Acquires IBIS’ iSPR Screening Platform
November 7, 2011 – AIMM Therapeutics and IBIS Technologies announced today the acquisition and implementation of IBIS’ MX96 System by AIMM.
Galapagos wins Scrip Award
November 4, 2011 – Galapagos won the prestigious Scrip Award for Biotech Company of the Year.
Genzyme and Cystic Fibrosis Foundation Collaborate
November 16, 2011 - Genzyme and Cystic Fibrosis Foundation Therapeutics, the nonprofit affiliate of the Cystic Fibrosis Foundation, today announced a research agreement to support the discovery of new drugs to treat people with the most common mutation found in patients with CF, Delta F508.
Follow us on Twitter!
November 18, 2011 - @AmsterdamBioMed: the latest news and updates from the Amsterdam BioMed Cluster.
Roadmaps topsector LSH
November 17, 2011 - The topsector Life Sciences & Health has formed a Taskforce Roadmaps that will draw the outlines within which government resources should be used and innovation contracts should be drawn up.
Interns in Sciences matches employers and students
November 22, 2011 - The collective Amsterdam-based Life Sciences educators ROC Amsterdam, Inholland and VU University, together with the Amsterdam BioMed Cluster, have launched an online ‘one-stop-shop’ for life sciences interns to supply all levels of the industry with students seeking practical work experience.
Dutch are interested in life sciences
November 21, 2011 - A survey by cluster organisation Life Sciences & Health (LSH) shows that only one third of the Dutch population knows the term 'life sciences & health'.
AMT Provides Business Update Q3
November 17, 2011 - Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, provided its non-audited business update in compliance with the EU transparency directive.
EU Orphan Designation for AMT's Hemophilia B Therapy
November 16, 2011 – The European Medicines Agency has granted orphan designation for Amsterdam Molecular Therapeutics' gene therapy program for the treatment of hemophilia B.
Microbiome wins 4th place in FD Gazellen
November 7, 2011 - Microbiome has reached the 4th place in the FD Gazellen Awards 2011 in the category small enterprises in the Utrecht region.
Former Abbott employees launch Consultancy
November 28, 2011 - On December 1, 2011 Pharma Holland Consultancy (PHC) will be launched officially.
Agilent makes acquisitions
December 1, 2011 - Agilent Technologies is expanding its life sciences business with strategic acquisitions.
Joint Venture Samsung and Biogen Idec
December 5, 2011 - Samsung and Biogen Idec have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars.
We need your input for the roadmaps
November 29, 2011 - Companies and knowledge institutes are asked to provide input for the topsector Life Sciences.
Schiphol wins Leading Edge Award
December 1, 2011 - Executive Travel Magazine, a magazine published by American Express in the United States, has awarded Amsterdam Airport Schiphol its Leading Edge Award for the third time.
The Netherlands tops Global Connectedness Index
December 1, 2011 - The Netherlands has been ranked first in the debut DHL Global Connectedness Index (GCI). This is a detailed country-by-country analysis of the various flows that connect nations around the world.
The Netherlands popular with international researchers
December 1, 2011 - Recent research has shown that the Netherlands is a popular destination for researchers from outside of the European Union.
Amsterdam in top 4 cities in which to do business
October 11, 2011 - According to a survey by global property consultant Cushman & Wakefield.
VUmc opens cancer center
September 28, 2011 - The VUmc Cancer Center, a modern center for the diagnosis and treatment of cancer, has officially opened its doors on September 28.
Industry and academia develop alternatives for antibiotics
December 7, 2011 - Science and industry together are working on the development of alternatives to antibiotics in livestock farming. The pharmaceutical industry is participating in the Immuno Valley program ALTANT.
VU researchers identify genes that influence platelets
December 8, 2011 - An international team of scientists, among whom are VU researchers, has identified 68 genomic loci reliably associated with the count and volume of platelets in blood.
Forbion unveils $50M fund for late-stage investments
December 8, 2011 - Forbion Capital Partners today announced the first and final closing of its second FCF 1 Co-Investment Fund at approximately $50m.
Construction of new labs and office space started
December 8, 2011 - Today saw the festive start of Matrix VI, an innovative and sustainable building providing lab and office space (6.000 m2) for start-ups, as well as services for life sciences companies.
Promotional film Amsterdam BioMed Cluster
December 12, 2011 - CityBiz has made a promotional film about Amsterdam that features the Amsterdam BioMed Cluster. The film will be shown in hotels and inflight entertainment.
Abbott and Reata Develop Next-Generation AIMs
December 12, 2011 - Abbott and Reata Pharmaceuticals have entered into a worldwide collaboration to jointly develop and commercialize Reata's portfolio of second-generation oral antioxidant inflammation modulators (AIMs).
Agendia Introduces SYMPHONY Breast Cancer Profile
December 6, 2011 – Agendia, an innovative molecular diagnostics company, today announced the introduction of formalin fixed, paraffin embedded tissue technology applied to their Symphony suite of breast cancer assays.
Ceronco wins Investors Forum at LS&H Conference
December 14, 2011 – Biotech company Ceronco has won the award for 'Best Pitch' at the yearly Dutch Life Sciences & Health Conference in Media Plaza Utrecht.
Genzyme Reports Top-line Results for TENERE Study
December 20, 2011 - Genzyme, a Sanofi company, reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a (Rebif), an approved injectable therapy, in people with relapsing forms of multiple sclerosis (RMS).
Obesity causes premature births
December 15, 2011 - AMC researchers have discovered that overweight/obesity has become an important contributor to the occurrence of adverse pregnancy outcomes in Amsterdam. For most outcomes, these contributions are larger than those for smoking.
AMT Announces Negative Equity Position
December 15, 2011 – Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, announced that the Company has a negative equity position, as a result of ongoing loss-making operations.
Abundnz accelerates development of innovative medicines
December 8, 2011 - Abundnz is a new analytical company that offers advanced analytical support to biotech industries developing innovative medicines.
Letter of Intent/Support for roadmaps LS&H online
December 20, 2011 - Topsector Life Sciences Health calls for your support.
VUmc opens breast milk bank
November 23, 2011 - VUmc has opened the first Dutch Breast Milk Bank.
Levin to succeed Yanai as CEO of Teva
January 3, 2012 - Teva Pharmaceutical Industries said its chief executive Shlomo Yanai will retire in May and be succeeded by Bristol-Myers Squibb Co. executive Jeremy Levin.
Physical activity improves learning
January 4, 2012 - Participation in physical activity is positively related to academic performance in children, VUmc researchers say.
Biogen Idec and Isis announce collaboration
January 4, 2012 - Biogen Idec and Isis Pharmaceuticals have entered into an exclusive, worldwide option and collaboration agreement under which the companies will develop and commercialize Isis’ antisense investigational drug, ISIS-SMNRx, for the treatment of spinal muscular atrophy.
Abbott Invests in NeuroGenetic Pharmaceuticals
January 4, 2012 — NeuroGenetic Pharmaceuticals, a privately held biopharmaceutical company focused on Alzheimer's disease therapeutics, has received an investment from Abbott Biotech Ventures.
Agendia Signs Contract with Blue Shield of California
January 5, 2012 – Agendia, an innovative molecular cancer diagnostics company, has signed a contract with Blue Shield of California, making Agendia an in-network provider.
Peter C. Wulff VP of Finance and CFO Agendia
January 9, 2012 – Agendia today announced that Peter C. Wulff has joined the company as Vice President of Finance and Chief Financial Officer.
AMT Receives US Orphan Designation for Hemophilia B Therapy
January 4, 2011 – Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its gene therapy program for the treatment of hemophilia B.
Philips and VUmc sign agreement for PET/MR scanner
December 22, 2011 - Royal Philips Electronics and the VU University Medical Center Amsterdam have signed an agreement to install one of Philips’ highly innovative Ingenuity TF PET/MR (Time-of-Flight Positron Emission Tomography/Magnetic Resonance) scanners at the center.
VUmc: supplemental oxygen not always good
January 11, 2012 - In medical emergencies, such as acute coronary syndrome, cardiopulmonary resuscitation (CPR), stroke, and exacerbations of chronic obstructive pulmonary disease (COPD), supplemental oxygen is often routinely administered.
